Is FFR dead? A conversation in cardiology

CONFLICTS OF INTEREST
Dr. Kern is a speaker for Abbott Vascular, Acist Medical Inc, Boston Scientific, Opsens Inc, Philips Inc. Dr. Fearon has research support from Abbott, Boston, Edwards, and Medtronic; consulting agreements with CathWorks and Siemens and equity options with HeartFlow. Dr. Johnson has received significant institutional research support from Philips Volcano Corporation (DEFINE-FLOW, NCT02328820); has an institutional licensing agreement with Boston Scientific for the smart-minimum FFR algorithm commercialized under 510(k) K191008; and has pending patents on diagnostic methods for quantifying aortic stenosis and TAVI physiology and on algorithms to correct pressure tracings from fluid-filled catheters. Dr. Moses has equity in Covanos. Dr. Pinto is a speaker for Abbott Vascular, Boston Scientific Inc. Dr. Teirstein Is a speaker for Acist Medical. Dr. Yeung is on the scientific board of Boston Scientific and Medtronic. The remaining authors declare no conflict of interest.